EUVIMEDEUVIMED entdecken
Kohortenstudie

Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study

Yongtai Cho, Suneun Park, Kyungyeon Jung, Jeong-Eun Lee, Jieun Woo, Ju Hwan Kim, Ju-Young Shin

BioDrugs · 2025

DOI: 10.1007/s40259-024-00689-8 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BioDrugs, 2025. Verfasst von Yongtai Cho und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, South Korea. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Psoriasis, Biological Products, Biological Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of Food and Drug Safety.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evidence comparing the impact of various biologics for psoriasis on the progression to psoriatic arthritis (PsA) is limited. We therefore assessed the risk of PsA associated with interleukin (IL)-23 inhibitor, IL-17 inhibitor, or IL-12/23 inhibitor use compared with tumor necrosis factor (TNF) inhibitor use among patients with psoriasis. METHODS: This population-based cohort study used the nationwide claims database from South Korea (2007-2023). New users of IL or TNF inhibitors with psoriasis who did not have PsA or other inflammatory arthritis were categorized into each class of the IL inhibitors for comparison with TNF inhibitor users. The outcome measured was the development of incident PsA. We calculated multinomial overlap weights to balance predefined covariates. Hazard ratio (HR) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards models. RESULTS: We identified 9499 patients with psoriasis (mean age 45.1 years; 33.6% female), of whom 3913 (41.2%), 2126 (22.4%), 2773 (28.8%), and 727 (7.7%) were exposed to IL-23 inhibitor, IL-17 inhibitor, IL-12/23 inhibitor, and TNF inhibitor, respectively. PsA developed in 281 (3.0%) patients during 23,275 person-years. The weighted HR for any IL inhibitors was 0.40 (95% CI 0.25-0.62), with specific HRs of 0.22 (95% CI 0.13-0.37), 0.47 (95% CI 0.28-0.80), and 0.46 (95% CI 0.29-0.74) for IL-23 inhibitor, IL-17 inhibitor, and IL-12/23 inhibitor, respectively. IL-23 inhibitors exhibited the greatest rate difference of - 2.61 (95% CI - 3.67 to - 1.55) cases of PsA per 100 person-years. CONCLUSIONS: The use of IL inhibitors, particularly IL-23 inhibitors, compared with TNF inhibitors, was associated with a lower risk of developing PsA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticPsoriasisBiological ProductsBiological TherapyHumansMaleFemaleMiddle AgedCohort StudiesAdultInterleukin-23Republic of KoreaTumor Necrosis Factor InhibitorsInterleukin-12Tumor Necrosis Factor-alphaInterleukin-17Proportional Hazards Models

Substanzen

Interleukin-23Tumor Necrosis Factor InhibitorsBiological ProductsInterleukin-12Tumor Necrosis Factor-alphaInterleukin-17

Autor:innen und Institutionen

  • School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, South Korea.
  • Department of Clinical and Social Pharmacy, Sungkyunkwan University, Suwon, South Korea.
  • Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
  • School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, South Korea. shin.jy@skku.edu.
  • Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea. shin.jy@skku.edu.
  • Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea. shin.jy@skku.edu.

Förderung

  • Ministry of Food and Drug Safety

Zitieren

APA

Cho, Y., Park, S., Jung, K., Lee, J. E., Woo, J., Kim, J. H., & Shin, J. Y. (2025). Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study. BioDrugs. https://doi.org/10.1007/s40259-024-00689-8

Vancouver

Cho Y, Park S, Jung K, Lee JE, Woo J, Kim JH, et al. Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study. BioDrugs. 2025. doi:10.1007/s40259-024-00689-8

BibTeX
@article{Cho2025,
  author = {Cho, Yongtai and Park, Suneun and Jung, Kyungyeon and Lee, Jeong-Eun and Woo, Jieun and Kim, Ju Hwan and Shin, Ju-Young},
  title = {Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study},
  journal = {BioDrugs},
  year = {2025},
  doi = {10.1007/s40259-024-00689-8}
}
Kostenlos starten →